XFOR Stock Summary and Trading Ideas (X4 Pharmaceuticals | NASDAQ:XFOR)

X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.

X4 Pharmaceuticals trades on the NASDAQ stock market under the symbol XFOR.

As of July 31, 2026, XFOR stock price declined to $3.98 with 407,756 million shares trading.

XFOR has a beta of 1.56, meaning it tends to be more sensitive to market movements. XFOR has a correlation of 0.04 to the broad based SPY ETF.

XFOR has a market cap of $375.39 million. This is considered a Small Cap stock.

Last quarter X4 Pharmaceuticals reported $3 million in Revenue and -$.16 earnings per share. This fell short of revenue expectation by $-662,000 and exceeded earnings estimates by $.04.

In the last 3 years, XFOR traded as high as $55.20 and as low as $1.35.

The top ETF exchange traded funds that XFOR belongs to (by Net Assets): VTI, IWM, VXF, IWN, VTWO.

XFOR has outperformed the market in the last year with a price return of +136.9% while the SPY ETF gained +19.4%. However, in the short term, XFOR had mixed performance relative to the market. It has underperformed in the last 3 months, returning -2.2% vs +4.2% return in SPY. But in the last 2 weeks, XFOR shares have fared better than the market returning +4.2% compared to SPY +0.5%.

XFOR support price is $3.82 and resistance is $4.18 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XFOR shares will trade within this expected range on the day.